A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...

Novo Nordisk A/S, GE HealthCare Technologies Inc. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.

The following content is for informational purposes only. This article is not intended to be a substitute for profession ...

Dr. Daniel Benhuri, a board-certified internal medicine and primary care physician, has been named the 2025 Top Patient Rated Primary Care Physician in Beverly Hills by Find Local Doctors. This ...

Doctors say new research has found a link between weight-loss drugs and cancer, putting users at 'significantly higher risk' ...

Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying ...

Dr. George Carroll runs BeSlimMD, a private weight loss clinic in Maitland. He has been helping patients lose weight for more than 40 years, but says when so called GLP-1 drugs made from semaglutide ...

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity ...

Prompt injection is the highest profile vulnerability in AI-powered features and applications. It's also one of the most misunderstood. The impact varies greatly depending on who will use the feature, ...